GSK PLC ADR GSK
News
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
ITeos Therapeutics Shares Rise on Positive Data From Lung Cancer Study
GSK Bets on Blood-Cancer Drug Comeback Amid Oncology Push
GSK's mRNA Flu Vaccine Advances to Late-Stage Clinical Development After Positive Trial Results
GSK Reaches Another Settlement in Zantac Litigation
GSK Says Herpes Vaccine Candidate Study Failed to Meet Primary Objective
Zenas BioPharma, Bicara Therapeutics sets IPO price ranges as summer lull ends
GSK's Asthma Treatment Shows Positive Results for Chronic Obstructive Pulmonary Disease
GSK shares jump on win in Delaware court over ongoing Zantac battle
5 things you need to know about COVID, flu and RSV vaccines this fall
GSK Wins Zantac Cancer Lawsuit in Florida
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
GSK's better-than-expected results overshadowed by Zantac litigation
GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales — Update
GSK Enters Partnership With Flagship Pioneering to Develop Up to 10 New Drugs